The Edmonton Oilers have another preseason tilt tonight against the Winnipeg Jets but still won’t have depth forward Josh Archibald in the lineup. Head coach Dave Tippett told reporters today that Archibald is getting blood work done to try and solve a mysterious medical issue:
Arch has skated for a few days and is having some tests done. He just can’t seem to get himself up to speed, he’s not feeling like he should be. The last couple days he’s had some testing done and we’re waiting for the results of that. He’s just not getting up to speed like he should be, so we just want to check where he’s at. He’s set back a couple days here.
Archibald is the only player on the Oilers that declined the COVID-19 vaccine, but Tippett confirmed that he has tested negative every day. The head coach also suggested Archibald actually might be currently ineligible to receive the vaccine because of this health issue even if he decided to get it now. The priority now is on the current health of the 28-year-old forward.
Entering the second season of a two-year, $3MM contract that was signed in 2020, Archibald has shown he can be a valuable bottom-six player for the Oilers. After scoring 12 goals in his first season in Edmonton, he came back with seven goals and 13 points in 52 games last year. While his playing time was certainly not guaranteed given the additions the team has made and the vaccination status that would keep him from traveling with the team at certain points, losing him entirely would certainly not be ideal at this juncture.
If Archibald is held out for this medical issue, it could be an opportunity for Colton Sceviour, in camp on a professional tryout, to land an NHL contract. The team will already be executing a delicate long-term injured reserve dance to get cap compliant, which should open enough room for another depth signing like Sceviour if there is a roster spot to be had.